Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1657-1663

  Hegyesi, H ^a   Darvas, Zs ^a   Laszlo V ^a   Pos Z ^a   Pallinger E ^b   Hirschberg, K ^a   Kovacs P ^a   Falus, András ^b,c  

^a Dept of Genet Cell and Immunbiol ^*  (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Histamine; Histamine receptors; Neuroblastoma; Retinoic acid; Tumor

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTIDINE DECARBOXYLASE; RETINOIC ACID; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROFILAMENT; PAJU CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; HISTAMINE; HISTIDINE DECARBOXYLASE; HUMANS; INTERMEDIATE FILAMENTS; NEUROBLASTOMA; NEURONS; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RNA, MESSENGER; TRETINOIN;

EID: 3242725122     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11, 1999.
2. Ciccarone V, Spengler BA, Meyers MB, Biedler JL and Ross RA: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49(1): 219-25, 1989.
3. Rodriguez J, Moran J, Blanco I and Patel AJ: Effect of histamine on the development of astroglial cells in culture. Neurochem Res 14: 693, 1989.
4. Van der Ven LTM, Prinsen IM, Jansen GH, Roholl PJM, Defferrari R, Slater R and Der Otten W: Growth of cultured glioma tumour cells can be regulated with histamine and histamine antagonists. Br J Cancer 68: 475-483, 1993.
5. Haussler M, Sidell N, Kelly M et al: Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines. Proc Natl Acad Sci USA 80: 5525-9, 1983.
6. Påhlman S, Ruusala AI, Abrahamsson L et al: Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14: 135-44, 1984.
7. Sidell N: Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68: 589-96, 1982.
8. Påhlman S, Odelstad L, Larsson E et al: Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13- acetate. Int J Cancer 28: 583-9, 1981.
9. Spinelli W, Sonnenfeld KH and Ishii DN: Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Cancer Res 42: 5067-73, 1982.
10. Rupniak HT, Rein G, Powell JF et al: Characteristics of a new human neuroblastoma cell line which differentiates in response to cyclic adenosine 3:5-monophosphate. Cancer Res 44: 2600-7, 1984.
11. Påhlman S and Hedborg F: Development of the neural crest and sympathetic nervous system. Brodeur GM, Sawada T, Tsuchida Y, Voute PA, eds. Neuroblastoma. New York, Elsevier. 2000. pp 9-19.
12. Yeger H, Baumal R, Pawlin G et al: Phenotypic and molecular characterisation of inducible human neuroblastoma cell lines. Differentiation 39: 216-27, 1988.
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival:Application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
14. Haak-Frendscho M, Darvas Zs, Hegyesi H, Kárpáti S, Hoffman RL, László V, Bencsáth M, Tímár J, Szalai Cs, Fûrész J, Pálinger É, Bata-Csorgo Z, Szabad G, Pivarcsi A, Horváth A, Dobozy A and Falus A: Histidine decarboxylase expression in human melanoma J Invest Dermatol 115(3): 345-352, 2000.
15. Boyne LJ, Fischer I and Shea TB: Role of vimentin in early stages of neuritogenesis in cultured hippocampal neurons. Int J Dev Neurosci. 14(6): 739-48, 1996.
16. Wainwright LJ, Lasorella A and Iavarone A: Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 98(16): 9396-400, 2001.
17. Miller W Jr: Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features [see comments]. Cancer Invest 14: 142-50, 1996.
18. Finklestein JZ, Krailo MD, Lenarsky C et al: 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Children's Cancer Study Group. Med Pediatr Oncol 20: 307-11, 1992.
19. Khan AA, Villablanca JG, Reynolds CP et al: Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother Pharmacol 39: 34-41, 1996.
20. Smith MA, Adamson PC, Balis FM et al: Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer [see comments]. J Clin Oncol 10: 1666-73, 1992.
21. Villablanca JG, Khan AA, Avramis VI et al: Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 13: 894-901, 1995.
22. Matthay KK, Villablanca JG and Seeger RC: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-73, 1999.
23. Ueda K: Detection of the retinoic acid-regulated genes in a RTBM1 neuroblastoma cell line using cDNA microarray. Kurume Med J 48(2): 159-64, 2001.